These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7128682)

  • 21. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of drugs on leukotrienes-, PAF-acether- and histamine- induced contractions of guinea-pig lung parenchymal strips.
    Touvay C; Vilain B; Etienne A; Clostre F; Braquet P
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():91-110. PubMed ID: 3022312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine release from rabbit platelets by platelet-activating factor (PAF).
    Nakahodo K; Saitoh S; Nakamura M; Kosugi T
    Arerugi; 1994 Mar; 43(3):501-10. PubMed ID: 7515227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis.
    Darius H; Lefer DJ; Smith JB; Lefer AM
    Science; 1986 Apr; 232(4746):58-60. PubMed ID: 3082008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M; Canciani MT; Mannucci PM
    Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mediators involved in endotoxin-induced vascular permeability increase in the rat skin and their interactions.
    Ueno A; Tokumasu T; Naraba H; Oh-ishi S
    Jpn J Pharmacol; 1996 Apr; 70(4):285-90. PubMed ID: 8774757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-lung in vivo interactions: an artifact of a multi-purpose model?
    Vargaftig BB; Lefort J; Prancan AV; Chignard M; Benveniste J
    Haemostasis; 1979; 8(3-5):171-82. PubMed ID: 511008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes.
    Korth R; Riess H; Brehm G; Hiller E
    Thromb Res; 1986 Mar; 41(5):699-706. PubMed ID: 3961742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.
    Sirois MG; de Lima WT; de Brum Fernandes AJ; Johnson RJ; Plante GE; Sirois P
    Br J Pharmacol; 1994 Apr; 111(4):1111-6. PubMed ID: 8032597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action.
    Nijkamp FP; Folkerts G; Beetens JR; De Clerck F
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):111-8. PubMed ID: 2571942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAF-induced bronchial hyperresponsiveness in the rabbit: contribution of platelets and airway smooth muscle.
    Coyle AJ; Spina D; Page CP
    Br J Pharmacol; 1990 Sep; 101(1):31-8. PubMed ID: 2282464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of paf-acether and related ether-lipid metabolism in platelets.
    Chignard M; Coëffier E; Benveniste J
    Adv Exp Med Biol; 1985; 192():309-26. PubMed ID: 2422886
    [No Abstract]   [Full Text] [Related]  

  • 34. Interactions between granulocytes and platelets with the guinea-pig lung in passive anaphylactic shock. Correlations with PAF-acether-induced lesion.
    Lellouch-Tubiana A; Lefort J; Pfister A; Vargaftig BB
    Int Arch Allergy Appl Immunol; 1987; 83(2):198-205. PubMed ID: 3583412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis.
    Kelefiotis D; Vakirtzi-Lemonias C
    Agents Actions; 1993 Nov; 40(3-4):150-6. PubMed ID: 8023738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor (PAF-acether): present status.
    Benveniste J
    Agents Actions; 1981 Dec; 11(6-7):542-4. PubMed ID: 6176101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection by nedocromil sodium of active immunization-induced bronchopulmonary alterations in the guinea pig.
    Pretolani M; Lefort J; Silva P; Malanchere E; Dumarey C; Bachelet M; Vargaftig BB
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1259-65. PubMed ID: 2160213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of prostacyclin and prostaglandin E1 on bronchoconstriction and thrombocytopenia during collagen and arachidonate infusions and anaphylactic shock in the guinea-pig.
    Vargaftig BB; Lefort J
    Prostaglandins; 1979 Oct; 18(4):519-28. PubMed ID: 394199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation.
    Lewis AJ; Dervinis A; Chang J
    Agents Actions; 1984 Dec; 15(5-6):636-42. PubMed ID: 6152379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.